Correction: MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors

Key Points

• The aim is to correct the previous findings regarding the silencing of MALAT1 in ESCC cells using microRNA.
• Correction of a published study's findings in Nanoscale.
• Focus on the role of ligand-functionalized hydroxyl-rich nanovectors.
• Examination of the effects across different ESCC cell lines.
• The correction clarifies the methodology regarding MALAT1 silencing.
• Emphasis on the significant role of microRNA in oncogenic processes in ESCC.
• Potential implications for enhancing targeted therapies in cancer treatment.